Heart failure & cardiomyopathies

Incremental prognostic value of epicardial adipose tissue volume and thickness assessed by cardiac MRI in hypertrophic cardiomyopathy

Eur Heart J Cardiovasc ImagingPublished retrospective cohort

Authors' conclusion

EATVI and regional fat thickness derived from CMR independently predict adverse outcomes in HCM and improve risk stratification. Comprehensive EAT assessment may serve as a promising imaging biomarker for personalized management.

Study context

Population
Hypertrophic cardiomyopathy (HCM) patients who underwent cardiac magnetic resonance (CMR) between 2018 and 2024
Participants
457 HCM patients
Exposure
Epicardial adipose tissue (EAT) parameters assessed by CMR for prediction of major adverse cardiovascular events (MACE)
Outcome
MACE
Follow-up
Median 27.5 months (interquartile range 15.6-47.6)

Main finding

As reported in the abstract

MACE occurred

18.1%

Observational data: associations, not effects.

Further findings

EATVI as predictor of MACE (multivariable Cox regression)

ComparisonHazard ratio (95% CI)P value
EATVIIndependent predictor1.03 (1.01–1.05)P < 0.001
OutcomePatients with MACEPatients without MACE
EATVImean 72.21 (SD 14.21) mL/m²mean 56.71 (SD 10.36) mL/m²
  • EATVI: P < 0.001

Regional fat thickness

Increased regional fat thickness in patients with MACE
P < 0.05

Discrimination of clinical-CMR model with EATVI

C-statistic
0.82-0.84
P
P = 0.002
Enhanced calibration and greater net clinical benefit on decision-curve analysis

EATVI appended to 2014 European Society of Cardiology (ESC) HCM Risk-SCD model

C-statistic 0.80 vs. 0.71
P < 0.001
Improved calibration

Event-free survival by EATVI quartiles and 62.5 mL/m² cutoff (Kaplan-Meier)

ESC-defined low-risk subgroup: curves separated significantly
log-rank P < 0.05
Progressively worse event-free survival with higher EATVI

Time-dependent receiver operating characteristic analyses

Stable predictive performance

Original publication

Incremental prognostic value of epicardial adipose tissue volume and thickness assessed by cardiac MRI in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. Published 11 November 2025. doi:10.1093/ehjci/jeaf305

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.